| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |